By Masood Sattar Khan (Pakistan News & Features Services) China will provide a coronavirus vaccine candidate developed by Sinopharm, a unit of the China National Pharmaceutical Group, to Pakistan as part of a trial agreement. The University of Karachi and Sinopharm are set to collaborate on vaccine trials and Pakistan will get vaccine doses sufficient to vaccinate one-fifth of its population. According to reports, the initial doses will be used to vaccinate the most vulnerable among the Pakistani population including the elderly, healthcare workers and people with medical conditions associated with serious cases of COVID-19. Earlier in April, Sinopharm had invited the National Institute of Health (NIH), Islamabad, to collaborate in conducting clinical trials of its inactivated vaccine for COVID-19 in Pakistan. In a letter sent to NIH Executive Director Maj Gen Dr Aamer Ikram, the general manager of China Sinopharm International Corp, Li Can, h...
Stay updated with Shehri TV for the latest Pakistan news, current affairs, entertainment, social issues, business, technology, sports, and trending videos from across the country. Pakistan News, Current Affairs, Karachi News, Business News, Technology News, Entertainment News, Sports News, Social Issues, Public Interest Stories, Latest Updates